Rede D'Or São Luiz (RDOR3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
29 May, 2026Executive summary
Gross revenue reached BRL 14.1 billion in Q1 2025, up 6.8% year-on-year, with consolidated EBITDA of BRL 2.3 billion, up 22.1%, and net income of BRL 1 billion, up 21.1% year-on-year.
SulAmérica's integration contributed to consolidated results, with net revenues up 12.2% year-on-year to over BRL 8 billion and membership growing 8.5% to 5.4 million beneficiaries.
Operational cash flow rose 85.1% year-on-year to BRL 3.2 billion.
Continued expansion of operational beds, reaching 10,148 at quarter-end, up 291 from year-end and 409 year-on-year.
Expansion included the inauguration of Barra D'Or and consolidation of São Luiz Campinas in Atlântica D'Or.
Financial highlights
Adjusted EBITDA, including insurance technical reserves, reached BRL 2.6 billion with a 20% margin; SulAmérica's adjusted EBITDA was BRL 986 million, up 106.4% year-on-year.
Gross revenue from hospital services was BRL 7.9 billion, up 6.8% year-on-year; oncology segment revenue was BRL 869 million, up 16.5% year-on-year.
Net debt stood at BRL 17.3 billion, with net debt/EBITDA at 1.7x, or 1.1x including technical provisions.
Administrative expenses held at 4.2% of revenue; hospital services G&A at 4.1% of gross revenue.
Gross margin for hospitals, oncology, and others was 21.6%, down 2.4 pp year-on-year.
Outlook and guidance
Ongoing organic expansion with 40 projects (4,036 beds) planned for delivery between 2025 and 2028.
Expecting accelerated ramp-up of new assets, especially Atlântica D'Or, and continued organic project deliveries.
Portfolio price adjustments and beneficiary growth expected to support continued revenue expansion.
Anticipate stronger bed growth in Q2 2025 due to ramp-up of new units, with seasonality expected to differ from previous years.
Maintaining financial discipline, with flexibility for new investments and share repurchases.
Latest events from Rede D'Or São Luiz
- Record Q3 revenue, profit, and cash flow, with margin gains and hospital expansion fueling growth.RDOR3
Q3 202418 May 2026 - Revenue and EBITDA surged, with strong operational, oncology, and insurance growth.RDOR3
Q1 202614 May 2026 - Record revenue, EBITDA, and net income growth with strong expansion and digital gains.RDOR3
Q4 20252 Mar 2026 - Record Q2 net income, revenue, and margins, with strong growth and improved leverage.RDOR3
Q2 20242 Feb 2026 - Record revenue, EBITDA, and net income driven by expansion and SulAmérica integration.RDOR3
Q4 20243 Dec 2025 - Record revenue, net income, and margin expansion highlight strong Q2 2025 performance.RDOR3
Q2 202523 Nov 2025 - Record revenue, net income, and patient growth, with strong expansion and improved leverage.RDOR3
Q3 20257 Nov 2025